Smith & Nephew
SNN

Smith & Nephew (SNN) news

Recent news

Smith & Nephew: BofA global research cuts price objective to 1,100.00p from 1,150.00p

AInvest Wire · Oct 6, 2026

Smith+Nephew - Announces Cartiheal Agili-C implant now available in Europe

Smith+Nephew (LSE:SN, NYSE:SNN) has announced that its CARTIHEAL AGILI-C Cartilage Repair Implant is now available in Europe for the treatment of cartilage and osteochondral defects in traumatic and osteoarthritic joints. The implant, developed by CartiHeal, a privately-held medical device company…

AInvest Wire · Oct 6, 2026

Surgical Innovations: Actively exploring additional routes to market and alternative distribution opportunities in the US

Surgical technology companies in the United States are actively exploring additional routes to market and alternative distribution opportunities to enhance their competitive positioning and expand market access. This strategic shift is driven by the need to adapt to evolving healthcare dynamics,…

AInvest Wire · Sep 30, 2026

Smith+Nephew - Landmark knee broader market availability expected throughout 2027

Smith+Nephew has announced that its newly developed knee implant, the Landmark knee, will see broader market availability across multiple regions by 2027. The company stated that the phased rollout is contingent on regulatory approvals and manufacturing capacity, with initial availability expected…

AInvest Wire · Sep 22, 2026

Smith & Nephew: Securities will be redeemed on October 5

Smith & Nephew plc has announced that securities will be redeemed on October 5, 2026. The company, a global medical technology firm, has not disclosed further details regarding the specific types of securities affected or the rationale behind the redemption. Investors are advised to consult the…

AInvest Wire · Sep 18, 2026

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.